Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 3-Dose vs 2-Dose Oral Ivermectin vs Topical Permethrin for Scabies
NCT05819983Phase 4Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Jan 2023
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin in scabies, sponsored by Universitas Padjadjaran. Started Jan 2023; status: completed.
02
Drugs
ivermectin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT05819983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05819983.